Skip to main content
About Us
Board
Careers
News, Events & Blog
Annual Report
Contact Us
Physicians
Insights
Clinical Trials
Relationship Opportunities
Physician Careers
Learn More
Patients
Resources
About Clinical Trials
Find a Clinical Trial
Practice Success
Practice Growth & Advocacy
Practice Management
Public Policy
Payer Strategy
Clinical Innovation
Precision Medicine
Clinical Research
Patient-Centric Care
Value-Based Care
Surgery
Radiation and Imaging
Clinical Services and Nursing
Submit
Home
>
Research
>
587P – Clinical and cost impact of cabazitaxel vs a second (ARTA) for patients with metastatic castration-resistant prostate cancer…
US Oncology Research Publications
« Back to All Resources
Poster
Prostate
Treatment
587P – Clinical and cost impact of cabazitaxel vs a second (ARTA) for patients with metastatic castration-resistant prostate cancer…
January 10, 2022
About Us
Board
Careers
News, Events & Blog
Annual Report
Contact Us
Physicians
Insights
Clinical Trials
Relationship Opportunities
Physician Careers
Learn More
Patients
Resources
About Clinical Trials
Find a Clinical Trial
Practice Success
Practice Growth & Advocacy
Practice Management
Public Policy
Payer Strategy
Clinical Innovation
Precision Medicine
Clinical Research
Patient-Centric Care
Value-Based Care
Surgery
Radiation and Imaging
Clinical Services and Nursing